SCHEMBL4146574

SCHEMBL4146574

CCCc1nn(C)c2c(=O)[nH]c(N(CCCc3ccccc3)Cc3sc(-c4ccccc4)nc3C)nc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 11/20 0.52
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
PDE1A P54750 1/20 0.41
PDE1B Q01064 1/20 0.41
KMT2A Q03164 1/20 0.41
PDE1C Q14123 1/20 0.41
PDE3A Q14432 3/20 0.40
PDE3B Q13370 2/20 0.40
MTOR P42345 1/20 0.39
TERT O14746 2/20 0.39
HDAC6 Q9UBN7 3/20 0.35
HDAC1 Q13547 2/20 0.35
HDAC2 Q92769 2/20 0.35
PDE6C P51160 2/20 0.35
HDAC3 O15379 1/20 0.35
NCOR2 Q9Y618 1/20 0.35
KDM4E B2RXH2 1/20 0.35
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906536 0.87 PDE5A (0.56) PDE5AMEN1ALDH1A1HPGDPDE1A
SCHEMBL4128530 0.85 PDE5A (0.49) PDE5AMEN1ALDH1A1HPGDPDE1A
SCHEMBL4901754 0.80 PDE5A (0.58) PDE5AMEN1ALDH1A1HPGDPDE1A
SCHEMBL4901747 0.77 PDE5A (0.57) PDE5AMEN1ALDH1A1HPGDPDE1A
SCHEMBL4893663 0.75 PDE5A (0.61) PDE5AMEN1ALDH1A1HPGDPDE1A
SCHEMBL4903689 0.74 PDE5A (0.62) PDE5AMEN1ALDH1A1HPGDPDE1A
SCHEMBL4897910 0.72 KDM4E (0.43) PDE5AALDH1A1KDM4EPOLB
SCHEMBL4894629 0.72 PDE5A (0.59) PDE5AMEN1ALDH1A1HPGDPDE1A
SCHEMBL7094075 0.72 PDE5A (0.67) PDE5AMEN1ALDH1A1HPGDPDE1A
SCHEMBL4902005 0.71 PDE5A (0.56) PDE5AMEN1ALDH1A1HPGDPDE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed